Your session is about to expire
Pravastatin vs Atorvastatin
Introduction
For patients struggling with high cholesterol levels or those at risk of heart disease, certain drugs that alter the concentration of lipoproteins in the blood can help manage symptoms and reduce risks. Pravastatin and Atorvastatin are two such drugs often prescribed for these conditions. Both belong to a class of medications known as statins which function by inhibiting an enzyme necessary for the production of cholesterol in the liver. However, they have different potencies and side effect profiles.
Pravastatin is hydrophilic (attracted to water), resulting in more selective uptake by the liver where it reduces LDL ("bad") cholesterol while slightly increasing HDL ("good") cholesterol levels. On the other hand, Atorvastatin is lipophilic (attracts fat) making it less specific to liver cells but potentially more potent overall; it significantly lowers LDL cholesterol and has moderate effects on raising HDL levels. Both can lower triglyceride levels though Atorvstatin may be more effective in this aspect.
Pravastatin vs Atorvastatin Side By Side
| Attribute | Pravachol | Lipitor |
|---|---|---|
| Brand Name | Pravachol | Lipitor |
| Contraindications | Should not be taken with drugs known as strong CYP3A4 inhibitors. | Should not be taken if you are taking drugs known as strong CYP3A4 inhibitors (such as itraconazole, telithromycin, HIV protease inhibitors). |
| Cost | For brand name, around $200 for 30 tablets of 40 mg. Generic versions can be as low as $0.10 to $0.50 per day. | For brand name, about $235 for 30 tablets of 40 mg. Generic versions average daily cost ranges from $0.15 up to about $0.75. |
| Generic Name | Pravastatin | Atorvastatin |
| Most Serious Side Effect | Muscle stiffness leading to severe muscle pain or tenderness (rhabdomyolysis), accompanied by fever and dark-colored urine. | Muscle pain or tenderness, which might indicate a serious condition called rhabdomyolysis. |
| Severe Drug Interactions | Fewer interactions due to its unique metabolism pathway which does not involve cytochrome P450 enzymes. | Can interact dangerously with atorvastatin and increase the risk of serious muscle problems. |
| Typical Dose | Oral dosages range from 10–80 mg/day, with a typical starting dose for adults often being 40 mg/day. | Therapy generally initiated at a dosage of 10-20 mg/day, can be adjusted up to 40-80 mg/day. |
What is Pravastatin?
Pravastatin (the generic name for Pravachol) was among the first statin medications designed to control and lower cholesterol levels within the body. It was approved by the FDA in 1991. Pravastatin works by blocking an enzyme in your liver that makes cholesterol, thereby reducing harmful LDL cholesterol and triglycerides while raising beneficial HDL cholesterol. This drug is prescribed primarily for preventing heart disease and strokes.
Atorvastatin (the generic name for Lipitor), on the other hand, is a more recent development in this class of drugs, gaining FDA approval in 1996. Like Pravastatin, it inhibits the same liver enzyme to reduce cholesterol production but tends to be more potent at lowering LDL levels due to its longer half-life and ability to bind better with blood plasma proteins.
While both medicines are effective at controlling high cholesterol, they have different side effect profiles. Atorvastatin may have a higher chance of causing muscle problems than pravastatin because it's more fat-soluble and can accumulate more readily within muscle tissues.
What conditions is Pravastatin approved to treat?
Pravastatin and Atorvastatin are both approved for the treatment of various lipid disorders including:
- Primary hypercholesterolemia, a condition characterized by high levels of cholesterol in the blood
- Mixed dyslipidemia, where there is an imbalance in your body's lipid levels
- Hypertriglyceridemia which means having high levels of triglycerides in the blood Atorvastatin is also approved to reduce the risk of stroke and heart attack in people with type 2 diabetes who have other risk factors for heart disease. Moreover, both drugs can be used as preventive measures against cardiovascular diseases.
How does Pravastatin help with these illnesses?
Pravastatin and Atorvastatin are both designed to manage high cholesterol levels by blocking the action of an enzyme in the liver called HMG-CoA reductase. This is a crucial enzyme involved in producing cholesterol in the body. By inhibiting its function, these medications can effectively reduce LDL (low-density lipoprotein), commonly known as "bad" cholesterol, and triglycerides while increasing HDL (high-density lipoprotein) or "good" cholesterol.
Both drugs belong to a class of medications called statins which have been shown to help prevent cardiovascular disease like stroke or heart attack, especially in patients with type 2 diabetes or other risk factors. However, they differ slightly; Atorvastatin is considered more potent and usually prescribed for individuals with significantly elevated LDL levels or those at higher risk of heart disease. Pravastatin has fewer interactions with other medications making it better suited for people who take multiple drugs.
What is Atorvastatin?
Atorvastatin, sold under the brand name Lipitor among others, is a statin medication used to prevent cardiovascular disease and manage abnormal lipid levels by inhibiting the enzyme HMG-CoA reductase. This inhibition controls the rate of cholesterol production in the body. First approved by FDA in 1996, Atorvastatin is one of the most potent statins available on market.
It's different from Pravastatin as it possesses both high efficacy and systemic reach because it's lipophilic (fat-soluble), which allows it to be active throughout your body unlike pravastatin which is hydrophilic (water soluble) limiting its action primarily to liver. The side-effect profile of Atorvastatin is somewhat similar to other statins with common adverse effects including muscle pain, feeling tired and minor digestive discomfort while severe side effects may include rhabdomyolysis and liver dysfunction. However, for patients who require more aggressive lowering of LDL ("bad") cholesterol level or those resistant to less potent agents like pravastain might find atrovastain beneficial.
What conditions is Atorvastatin approved to treat?
Atorvastatin is a cholesterol-lowering medication that has been approved for the treatment of:
- Primary prevention of heart disease in individuals with multiple risk factors
- Secondary prevention in patients with established heart disease
- Hypercholesterolemia (high levels of cholesterol in the blood)
- Mixed dyslipidemia, which involves abnormal levels of different types of lipids or fats in your blood.
How does Atorvastatin help with these illnesses?
Atorvastatin, like pravastatin, is a statin medication used to manage high cholesterol levels and reduce the risk of cardiovascular disease. Statins work by inhibiting an enzyme called HMG-CoA reductase, which plays a crucial role in the production of cholesterol in the liver. Atorvastatin is particularly potent and can lower LDL ("bad") cholesterol significantly more than pravastatin. This makes it especially beneficial for patients with very high LDL levels or those at increased risk of heart disease due to other factors such as diabetes or hypertension. It's also worth noting that while both drugs are generally well-tolerated, atorvastatin may cause side effects more frequently than pravastatin due to its greater potency; however, these are typically mild and manageable.
How effective are both Pravastatin and Atorvastatin?
Both pravastatin and atorvastatin are effective statins that have been widely used for the treatment of high cholesterol, approved by the FDA in 1991 and 1996 respectively. Both medications work by blocking a key enzyme (HMG-CoA reductase) in the liver that is responsible for making cholesterol. A direct comparison study conducted in 2003 revealed that both drugs were similarly effective in reducing total cholesterol levels, although atorvastatin was found to be more potent on a milligram per milligram basis.
A meta-analysis from 2010 confirmed pravastatin's effectiveness in lowering LDL ("bad") cholesterol levels as well as raising HDL ("good") cholesterol levels starting with the first week of treatment. Pravastatin was also reported to have fewer drug interactions compared to other statins due to its unique metabolism pathway which does not involve cytochrome P450 enzymes present within the liver. This makes it a favorable choice among patients who take multiple medications.
On the other hand, a large review published in The Lancet journal demonstrated atorvastatin’s superior potency across several measures including reductions of LDL-cholesterol, total cholesterol and triglycerides when compared directly against pravastatin and other statins. However, this increased potency may come with an increased risk for certain side effects such as muscle-related complications or elevated liver enzymes.
While both medications can effectively reduce cardiovascular disease risk through their lipid-lowering effects, individual patient characteristics like kidney function status or concurrent medication usage might tip favor towards one over another.
Related trials for pravastatin and atorvastatin
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Pravastatin typically prescribed?
Oral dosages of Pravastatin range from 10–80 mg/day, with studies showing that a typical starting dose for adults is often 40 mg/day for reducing cholesterol and triglyceride levels. Children and adolescents aged 8-18 years may be started on 20 mg/day. In both populations, dosage can be adjusted after several weeks depending on the response. The maximum dosage that should not exceeded in any case is 80 mg/day.
On the other hand, Atorvastatin doses vary between 10–80 mg daily depending upon the severity of high cholesterol condition. For most people, including children above ten years old and adults, the recommended starting dose is usually 10 or 20mg once daily which could be increased over time based on individual responses to treatment. However, under no circumstances should a patient exceed an intake of more than 80mg per day.
At what dose is Atorvastatin typically prescribed?
Atorvastatin therapy is generally initiated at a dosage of 10-20 mg/day, which can be adjusted based on the patient's LDL (low-density lipoprotein) levels and overall response to treatment. The dose can then be increased up to 40-80 mg/day if needed. It's important that doses are taken once daily, usually in the evening as this is when most cholesterol is produced by your body. This medication should not exceed a maximum dose of 80 mg per day, and it may take several weeks before you notice any significant changes in your cholesterol levels.
What are the most common side effects for Pravastatin?
Common potential side effects for both pravastatin and atorvastatin include:
- Headache
- Nausea, stomach pain, constipation or diarrhea
- Rashes
- Muscle and joint pain (myalgia)
- Insomnia
- Dizziness
- Mild memory problems or confusion
- Increased blood sugar levels
It's important to note that these medications can occasionally cause muscle inflammation or damage. If you experience unexplained muscle pain, tenderness, weakness accompanied by fever or unusual tiredness while taking either of these drugs, it’s crucial to contact your doctor immediately. Additionally, both drugs may rarely cause liver disease; if you notice any symptoms such as persistent nausea/vomiting, loss of appetite, abdominal/stomach pain or yellowing of eyes/skin (jaundice), seek medical attention promptly.
Are there any potential serious side effects for Pravastatin?
While both Pravastatin and Atorvastatin are generally well-tolerated, they can cause potential side effects in rare cases. They do not typically increase thoughts about suicide or self-harm. However, here are some symptoms that may occur:
- Signs of an allergic reaction, such as hives; difficulty breathing; swelling of your face, lips, tongue, or throat
- Symptoms of liver problems like persistent nausea/vomiting; loss of appetite; stomach/abdominal pain; yellowing eyes/skin (jaundice); dark urine
- Changes in vision: blurred vision or other alterations
- Rapid or pounding heartbeats
- Shortness of breath and sudden dizziness which makes you feel as if you might faint
- Muscle stiffness leading to severe muscle pain or tenderness (a condition called rhabdomyolysis), accompanied by fever and dark-colored urine. This could potentially lead to kidney issues.
Always remember that while these side effects are possible with statin use, their occurrence is quite rare. If any such symptoms arise during treatment with Pravastatin or Atorvastatin drugs, it's important to seek immediate medical attention.
What are the most common side effects for Atorvastatin?
Atorvastatin, a commonly prescribed statin for managing high cholesterol levels, may have various potential side effects:
- Mild nausea or stomach pain
- Headache and dizziness
- Nasal congestion or stuffy nose
- Sore throat
- Constipation or diarrhea
- Muscle or joint pain can occur as an adverse effect. In rare instances, it may cause muscle breakdown leading to kidney failure.
- It can also trigger allergic reactions like rash.
- Sleep problems (insomnia)
Please note that while these are possible side effects, they do not occur in everyone and many people experience no side effects at all. However, if you notice any of these symptoms persistently after starting Atorvastatin, consult your healthcare provider promptly.
Are there any potential serious side effects for Atorvastatin?
Atorvastatin, while typically well-tolerated, can present side effects that may require medical attention. Users should be aware of:
- Signs of an allergic reaction: hives; difficulty breathing; swelling in your face or throat
- Unusual fatigue or weakness
- Dark colored urine
- Muscle pain or tenderness, which might indicate a serious condition called rhabdomyolysis
- Yellowing eyes/skin (jaundice), pointing to liver problems
- Change in the amount of urine passed, suggesting kidney issues
- Severe nausea and vomiting
If you experience any of these symptoms after taking Atorvastatin, cease usage and immediately seek medical advice.
Contraindications for Pravastatin and Atorvastatin?
Both pravastatin and atorvastatin, like most other cholesterol-lowering medications, may cause side effects in some people. If you notice muscle pain or weakness, dark colored urine, unusual fatigue or loss of appetite, please seek immediate medical attention.
Neither pravastatin nor atorvastatin should be taken if you are taking drugs known as strong CYP3A4 inhibitors (such as itraconazole, telithromycin, HIV protease inhibitors). Always inform your physician about all the medications you are currently taking; these inhibitor drugs can interact dangerously with atorvastatin and increase the risk of serious muscle problems.
Pravastatin is not metabolized by CYP3A4 enzymes so it does not have this interaction risk but still requires careful use alongside other medications. Informing your doctor about all your current prescriptions ensures a safe treatment plan to reduce cholesterol levels effectively.
How much do Pravastatin and Atorvastatin cost?
For the brand name versions of these drugs:
- The price for 30 tablets of Pravachol (pravastatin), 40 mg each, averages around $200 in the United States. This works out to approximately $6–7/day depending on your dose.
- The cost for a similar quantity of Lipitor (atorvastatin), also at 40 mg per tablet, is about $235. That translates to roughly $8/day.
Therefore, if you are prescribed a high dosage of these medications or need long-term treatment, branded pravastatin may be less expensive on a daily basis than its counterpart, Lipitor. However, it's crucial that cost does not dictate which medication is right for you - this decision should always be based on what best suits your medical needs and circumstances.
When considering generic versions:
- Generic pravastatin can be purchased with costs as low as $0.10 to $.50 per day when taking typical doses that range from 20mg to 80mg daily.
- Atorvastatin also comes in a cheaper generic form with an average daily cost ranging from $.15 up to about $.75 depending upon the required dosage.
Again, while both are significantly lower-priced options compared to their brand-name equivalents, decisions regarding medication should prioritize health benefits over financial considerations.
Popularity of Pravastatin and Atorvastatin
Pravastatin and atorvastatin are both statins, a class of drugs used to lower cholesterol levels. They work by inhibiting the enzyme HMG-CoA reductase, which plays a crucial role in the production of cholesterol in the liver.
Atorvastatin, often recognized under its brand name Lipitor, is one of the most commonly prescribed statin medications. In 2020 alone, approximately 87 million prescriptions were filled for atorvastatin in the United States. This accounts for about 42% of all statin prescriptions.
On the other hand, pravastatin (also known as Pravachol) was prescribed to around 15 million patients during that same period. Pravastatin makes up roughly 7% of all statin prescriptions within America. The use of pravastatin has been generally stable over recent years whereas atorvastatin saw an increase when it became available as a generic medication from around 2011 onward.
Both drugs have proven effective at reducing LDL ("bad") cholesterol levels and modestly increasing HDL ("good") cholesterol levels but they do differ slightly in their side effect profiles and interactions with food or other drugs.
Conclusion
Both pravastatin and atorvastatin have a well-established history of use in managing high cholesterol levels, with numerous clinical studies indicating their efficacy over placebo treatments. These medications belong to the statin family and work by inhibiting an enzyme called HMG-CoA reductase that plays a crucial role in cholesterol production in the liver.
Pravastatin is often used as a first-line treatment for those newly diagnosed with high cholesterol or who are at moderate risk of heart disease due to its favorable safety profile. In comparison, atorvastatin tends to be prescribed for patients with higher cholesterol levels or established cardiovascular disease due to its potent lipid-lowering capabilities.
Both drugs are available generically, representing significant cost savings for patients particularly those paying out-of-pocket. The effects of both pravastatin and atorvastatin may not be apparent right away, as it typically takes several weeks before they significantly lower blood cholesterol levels.
In terms of side effects, both drugs are generally well-tolerated but can cause muscle pain or damage in rare cases. Pravastatin has fewer interactions with other medicines than does atorvastatin; therefore it's usually preferred if you take multiple medications. It is important that patients monitor their health regularly while on these therapies and seek immediate medical help if they experience severe muscle pain or signs suggestive of liver injury such as jaundice.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Dallongeville, J., Fruchart, J.-C., Maigret, P., Bertolini, S., Bittolo Bon, G., Campbell, M. M., … Sirtori, C. (1998, June). Double-Blind Comparison of Apolipoprotein and Lipoprotein Particle Lowering Effects of Atorvastatin and Pravastatin Monotherapy in Patients With Primary Hypercholesterolemia. Journal of Cardiovascular Pharmacology and Therapeutics. SAGE Publications.http://doi.org/10.1177/107424849800300202
- Lee, C. W., Baek, S.-H., Hong, T.-J., Choi, Y.-J., Kim, Y.-J., Ahn, T.-H., … Kim, H.-S. (2010, April). A Multicenter, Eight-Week Treatment, Single-Step Titration, Open-Label Study Assessing the Percentage of Korean Dyslipidemic Patients Achieving LDL Cholesterol Target with Atorvastatin Starting Doses of 10 mg, 20 mg and 40 mg. Cardiovascular Drugs and Therapy. Springer Science and Business Media LLC.http://doi.org/10.1007/s10557-010-6225-0
- Menon, P. D., Singh, T., Hubbard, H., Hackman, S., & Sharkey, F. E. (2020, February 13). Cholangiolytic Changes in Statin-Induced Liver Injury. Case Reports in Pathology. Hindawi Limited.http://doi.org/10.1155/2020/9650619
- Kokilambigai, K. S., Seetharaman, R., & Lakshmi, K. S. (2017, June 23). Critical Review on the Analytical Techniques for the Determination of the Oldest Statin—Atorvastatin—in Bulk, Pharmaceutical Formulations and Biological Fluids. Critical Reviews in Analytical Chemistry. Informa UK Limited.http://doi.org/10.1080/10408347.2017.1342529
- Lea, A. P., & McTavish, D. (1997, May). Atorvastatin. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-199753050-00011
- Avisar, I., Brook, J. G., & Wolfovitz, E. (2008, May). Atorvastatin monotherapy vs. combination therapy in the management of patients with combined hyperlipidemia. European Journal of Internal Medicine. Elsevier BV.http://doi.org/10.1016/j.ejim.2007.09.004
- Siddiq, A., Khan, R., & Baig, S. (2011). Does atorvastatin work more effectively than biguanides in reducing cardiovascular risk factors?. Journal of Pharmacy And Bioallied Sciences. Medknow.http://doi.org/10.4103/0975-7406.80767
- Mohamed, M. F. H., Salameh, O. K., & Saeed, A. A. M. (2019, May 18). Statin-Induced Rhabdomyolysis, Acute Kidney Injury, and Hepatitis Leading to Death. American Journal of Case Reports. International Scientific Information, Inc.http://doi.org/10.12659/ajcr.914707
- Black, D. M., Bakker-Arkema, R. G., & Nawrocki, J. W. (1998, March 23). An Overview of the Clinical Safety Profile of Atorvastatin (Lipitor), a New HMG-CoA Reductase Inhibitor. Archives of Internal Medicine. American Medical Association (AMA).http://doi.org/10.1001/archinte.158.6.577
- Paoletti, R., Corsini, A., & Bellosta, S. (2002, May). Pharmacological interactions of statins. Atherosclerosis Supplements. Elsevier BV.http://doi.org/10.1016/s1567-5688(02)00002-8
- Korman, L., & Borysiuk, L. (1995, May 15). Replacing lovastatin with pravastatin: Effect on serum lipids and costs. American Journal of Health-System Pharmacy. Oxford University Press (OUP).http://doi.org/10.1093/ajhp/52.10.1078
- Rajaram, M. (2009, February 2). Hepatitis, rhabdomyolysis and multi-organ failure resulting from statin use. Case Reports. BMJ.http://doi.org/10.1136/bcr.07.2008.0412
- Raasch, R. H. (1991, April). Pravastatin Sodium, a New Hmg-CoA Reductase Inhibitor. Dicp. SAGE Publications.http://doi.org/10.1177/106002809102500410